Literature DB >> 12716027

Tolerance to diazepam-induced motor impairment: a study with GABAA receptor alpha6 subunit knockout mice.

Olga Vekovischeva1, Mikko Uusi-Oukari, Esa R Korpi.   

Abstract

Development of tolerance to motor-impairing effects of repeated administration of moderate diazepam doses (5.0-7.5 mg/kg; three times daily PO 3 weeks) was compared between mice deficient in the cerebellar granule cell-restricted GABAA receptor alpha6 subunit and their wild-type controls. The alpha6 -/- mice were more impaired by the initial challenge doses of diazepam (5 or 10 mg/kg) than their controls, but acquired partial tolerance by the second tests with the same doses 4-7 days later. Chronic treatment produced complete tolerance in both mouse lines. Ligand autoradiography revealed a significant reduction in baseline benzodiazepine and chloride channel site-bindings in various regions of the alpha6 -/- brains, but the chronic diazepam treatment did not consistently alter baseline or benzodiazepine site agonist and inverse agonist-modulated binding in the alpha6 -/- and wildtype mice. The results indicate that tolerance to motor-impairing actions of diazepam is independent of the diazepam-insensitive alpha6 subunit-containing receptors, which rules out the possibility that tolerance emerges as an increase in structurally benzodiazepine-insensitive receptor population.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12716027     DOI: 10.1023/a:1022870002722

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  33 in total

Review 1.  GABA(A) receptor subtypes: dissecting their pharmacological functions.

Authors:  U Rudolph; F Crestani; H Möhler
Journal:  Trends Pharmacol Sci       Date:  2001-04       Impact factor: 14.819

2.  Substrate specificity of diazepam-insensitive cerebellar [3H]Ro 15-4513 binding sites.

Authors:  E R Korpi; M Uusi-Oukari; K Wegelius
Journal:  Eur J Pharmacol       Date:  1992-03-31       Impact factor: 4.432

3.  Chronic benzodiazepine treatment of cells expressing recombinant GABA(A) receptors uncouples allosteric binding: studies on possible mechanisms.

Authors:  N J Ali; R W Olsen
Journal:  J Neurochem       Date:  2001-12       Impact factor: 5.372

4.  GABAA receptor blockers reverse the inhibitory effect of GABA on brain-specific [35S]TBPS binding.

Authors:  R F Squires; E Saederup
Journal:  Brain Res       Date:  1987-06-30       Impact factor: 3.252

5.  Ethanol tolerance and withdrawal responses in GABA(A) receptor alpha 6 subunit null allele mice and in inbred C57BL/6J and strain 129/SvJ mice.

Authors:  G E Homanics; N Q Le; F Kist; R Mihalek; A R Hart; J J Quinlan
Journal:  Alcohol Clin Exp Res       Date:  1998-02       Impact factor: 3.455

6.  Long-range interactions in neuronal gene expression: evidence from gene targeting in the GABA(A) receptor beta2-alpha6-alpha1-gamma2 subunit gene cluster.

Authors:  M Uusi-Oukari; J Heikkilä; S T Sinkkonen; R Mäkelä; B Hauer; G E Homanics; W Sieghart; W Wisden; E R Korpi
Journal:  Mol Cell Neurosci       Date:  2000-07       Impact factor: 4.314

7.  Adaptive regulation of neuronal excitability by a voltage-independent potassium conductance.

Authors:  S G Brickley; V Revilla; S G Cull-Candy; W Wisden; M Farrant
Journal:  Nature       Date:  2001-01-04       Impact factor: 49.962

8.  Chronic administration of diazepam to rats causes changes in EEG patterns and in coupling between GABA receptors and benzodiazepine binding sites in vitro.

Authors:  L Mele; S Sagratella; M Massotti
Journal:  Brain Res       Date:  1984-12-03       Impact factor: 3.252

9.  A single histidine in GABAA receptors is essential for benzodiazepine agonist binding.

Authors:  H A Wieland; H Lüddens; P H Seeburg
Journal:  J Biol Chem       Date:  1992-01-25       Impact factor: 5.157

10.  High affinity ligands for 'diazepam-insensitive' benzodiazepine receptors.

Authors:  G Wong; P Skolnick
Journal:  Eur J Pharmacol       Date:  1992-01-14       Impact factor: 4.432

View more
  2 in total

1.  Anxiolytic properties of new chemical entity, 5TIO1.

Authors:  Amanda C Fortes; Antonia Amanda C Almeida; Francisco Jaime B Mendonça-Júnior; Rivelilson M Freitas; José Lamartine Soares-Sobrinho; Monica Felts de La Roca Soares
Journal:  Neurochem Res       Date:  2013-01-19       Impact factor: 3.996

2.  Psychopharmacological effects and safety of styryl-2-pyrones and dihydrostyryl-2-pyrones-rich fraction from Polygala sabulosa: absence of withdrawal syndrome and tolerance to anxiolytic-like and anticonvulsant effects.

Authors:  Filipe Silveira Duarte; Marcelo Duzzioni; Rafael Luiz Prim; Alcíbia Maia Cardozo; Claudia Regina Dos Santos; Maria Goretti da Silva; Maria Beatriz Cacese Shiozawa; Beatriz Garcia Mendes; Tiago Tizziani; Inês Maria Costa Brighente; Moacir Geraldo Pizzolatti; Thereza Christina Monteiro de Lima
Journal:  J Pharm Pharmacol       Date:  2018-06-28       Impact factor: 3.765

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.